LYZZ Capital logo

LYZZ Capital

Asia, Shanghai, China, Shanghai

Description

LYZZ Capital is a venture capital firm specialized in seed, early, and expansion stage venture investments.

Investor Profile

LYZZ Capital has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 13% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (63%)
  • Series A (25%)
  • Series D (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Wellness
  • Health Diagnostics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LYZZ Capital frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Madison Partners
North America, California, United States, Los Angeles
Co-Investments: 2
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Boehringer Ingelheim Venture Fund
Europe, Rheinland-Pfalz, Germany, Ingelheim Am Rhein
Co-Investments: 2
City Hill Ventures
North America, California, United States, San Diego
Co-Investments: 2
Delos Capital
North America, New York, United States, New York
Co-Investments: 2
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 2
Korea Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Xeraya Capital
Asia, Kuala Lumpur, Malaysia, Kuala Lumpur
Co-Investments: 2
B Capital
North America, California, United States, Manhattan Beach
Co-Investments: 2

What are some of recent deals done by LYZZ Capital?

Wugen

St Louis, Missouri, United States

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

BiotechnologyTherapeutics
Series CAug 27, 2025
Amount Raised: $115,000,000
OncoMyx Therapeutics

Phoenix, Arizona, United States

OncoMyx Therapeutics develops oncolytic immunotherapies to assist in creating an immune response and treat cancer.

BiotechnologyHealth DiagnosticsMedicalTherapeutics
Series BDec 9, 2021
Amount Raised: $50,000,000
Viron

Boston, Massachusetts, United States

Viron Inc. is based in Boston, MA

Health Care
Series BDec 8, 2021
Amount Raised: $50,000,000
Wugen

St Louis, Missouri, United States

Wugen is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

BiotechnologyTherapeutics
Series BJul 15, 2021
Amount Raised: $172,000,000
Neurelis

Encinitas, California, United States

Neurelis is a specialty pharmaceutical company providing a highly differentiated approach to target unmet medical needs.

BiotechnologyHealth CareMedicalPharmaceutical
Series DMar 10, 2021
Amount Raised: $114,000,000
Jumpcode Genomics

Carlsbad, California, United States

JUMPCODE's CRISPR-mediated rRNA depletion kits remove nucleic acids from sequencing workflows to improve sensitivity and performance.

BiotechnologyHealth CareWellness
Series BJan 20, 2021
Amount Raised: $21,000,000
Onchilles Pharma

San Diego, California, United States

Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.

BiopharmaBiotechnologyPharmaceutical
Series AJul 10, 2020
Amount Raised: $7,000,000
Qpex Biopharma

San Diego, California, United States

Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases.

BiotechnologyHealth Care
Series AOct 22, 2018
Amount Raised: $33,000,000
Neurelis

Encinitas, California, United States

Neurelis is a specialty pharmaceutical company providing a highly differentiated approach to target unmet medical needs.

BiotechnologyHealth CareMedicalPharmaceutical
Series BJan 5, 2017
Amount Raised: $42,098,000